Bracaloc 150mg Olaparib Tablet

Bracaloc 150mg Olaparib Tablet is a prescription targeted anti-cancer medication used in the treatment of certain BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. It contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor that works by preventing cancer cells from repairing damaged DNA, leading to their destruction while minimizing damage to healthy cells. Bracaloc 150mg Tablet helps slow cancer progression and is often used as maintenance therapy or as part of a comprehensive treatment plan for eligible patients. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to assess treatment effectiveness and manage potential side effects. Patients should use Bracaloc 150mg Olaparib Tablet only as prescribed by their healthcare provider and follow all recommended medical appointments during treatment.